Low "quotient" Lp(a) concentration mediates autoimmune activation and independently predicts cardiometabolic risk.

doi:10.1055/s-0034-1385922

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Low "quotient" Lp(a) concentration mediates autoimmune activation and independently predicts cardiometabolic risk.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association - 1 Jan 2015

Onat A, Çoban N, Can G, Yüksel M, Karagöz A, Yüksel H, Ademoğlu E, Erginel-Ünaltuna N

Abstract excerpt

OBJECTIVE: We determined whether U-shaped relationships exist between serum lipoprotein[Lp](a) and cardiometabolic risk. METHODS: In population-based nondiabetic and diabetic middle-aged adults (n=1 428 and 241, respectively) who had been genotyped for the LPA rs10455872 A>G polymorphism, we adjusted the Lp(a) concentration for the effects of genotype and other covariates. Via sex-specific equations we estimated...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autoimmunity

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cholesterol

Share to Coronary Disease

Share to Diabetes Mellitus

Share to Follow-Up Studies

Share to Insulin

Share to Lipoprotein(a)

Share to Risk Factors

Source

Open in PubMed

Identifiers

PMID: 25314652
DOI: 10.1055/s-0034-1385922

Genes

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Low "quotient" Lp(a) concentration mediates autoimmune activation and independently predicts cardiometabolic risk.PMID 25314652Read ↗

Are Lipoprotein(a) levels decreased in insulin resistance and type 2 diabetes?Semantic proximity Read ↗

Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association.Semantic proximity Read ↗

Lipoprotein(a)Semantic proximity Read ↗

Lipoprotein(a) as a potential causal genetic risk factor of cardiovascular disease: a rationale for increased efforts to understand its pathophysiology and develop targeted therapies.Semantic proximity Read ↗

Lipoprotein(a): more interesting than ever after 50 years.Semantic proximity Read ↗

Lipoprotein (a): An Update on a Marker of Residual Risk and Associated Clinical Manifestations.Semantic proximity Read ↗

Enigmatic role of lipoprotein(a) in cardiovascular disease.Semantic proximity Read ↗

What Is Currently Understood and Remains Undiscovered regarding Lp(a) in the Context of Metabolic Syndrome?Semantic proximity Read ↗

Genetic variants, plasma lipoprotein(a) levels, and risk of cardiovascular morbidity and mortality among two prospective cohorts of type 2 diabetes.Semantic proximity Read ↗

Low-molecular-weight lipoprotein (a) and low relative lymphocyte concentration are significant and independent risk factors for coronary heart disease in patients with type 2 diabetes mellitus: Lp(a) phenotype, lymphocyte, and coronary heart disease.Semantic proximity Read ↗

Low lipoprotein(a) levels and risk of disease in a large, contemporary, general population study.Semantic proximity Read ↗

Lipoprotein(a) and Atherosclerotic Cardiovascular Disease: Where Do We Stand?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.